Company Overview of U3 Pharma GmbH
U3 Pharma GmbH, a clinical-stage biopharmaceutical company, develops protein therapeutics for the treatment of cancer. The company’s drug development pipeline comprises antibodies and antibody-drug-conjugates. Its medicines are directed against cancer but selected drugs also have potential for treating cardiovascular or metabolic diseases. The company was founded in 2001 and is based in Martinsried, Germany. As of June 19, 2008, U3 Pharma GmbH operates as a subsidiary of Daiichi Sankyo Company, Limited.
Founded in 2001
49 89 8103 9100
49 89 8103 9199
Key Executives for U3 Pharma GmbH
Similar Private Companies By Industry
|Merz GmbH & Co. KGaA||Europe|
|Boehringer Ingelheim Vetmedica Gmbh||Europe|
|Pfizer Consumer Healthcare GmbH||Europe|
|E. Merck KG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact U3 Pharma GmbH, please visit www.u3pharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.